Table 4.
Complication | Parameter | MPR level | ||||
Excellent | Good | Normal | Bad | Very bad | ||
CAD | Events (N) | 2081 | 811 | 635 | 535 | 405 |
IR per 1000 PYR | 4 | 5.1 | 5.5 | 5.6 | 5.5 | |
HR* (95% CI) | Ref | 1.26 (1.16 to 1.37)§ | 1.35 (1.23 to 1.47)§ | 1.38 (1.26 to 1.52)§ | 1.38 (1.24 to 1.53)§ | |
P value | – | <0.001 | <0.001 | <0.001 | <0.001 | |
Vascular complications | Events (N) | 393 | 154 | 120 | 107 | 89 |
IR per 1000 PYR | 0.7 | 1 | 1 | 1.1 | 1.2 | |
HR* (95% CI) | Ref | 1.25 (1.04 to 1.51)† | 1.33 (1.08 to 1.63)‡ |
1.45 (1.17 to 1.79)§ | 1.59 (1.26 to 2.00)§ | |
P value | – | 0.018 | 0.007 | 0.001 | <0.001 | |
Cerebrovascular disease | Events (N) | 3613 | 1312 | 1120 | 997 | 775 |
IR per 1000 PYR | 6.9 | 8.4 | 9.8 | 10.6 | 10.8 | |
HR* (95% CI) | Ref | 1.18 (1.11 to 1.26) § | 1.38 (1.29 to 1.47) § | 1.51 (1.41 to 1.62) § | 1.54 (1.43 to 1.67) § | |
P value | – | <0.001 | <0.001 | <0.001 | <0.001 | |
Heart disease | Events (N) | 2585 | 981 | 788 | 659 | 540 |
IR per 1000 PYR | 4.9 | 6.2 | 6.8 | 6.9 | 7.4 | |
HR* (95% CI) | Ref | 1.21 (1.13 to 1.30)§ | 1.33 (1.23 to 1.44)§ | 1.36 (1.25 to 1.48)§ | 1.47 (1.34 to 1.62)§ | |
P value | – | <0.001 | <0.001 | <0.001 | <0.001 | |
Hypertensive nephropathy | Events (N) | 633 | 278 | 232 | 194 | 147 |
IR per 1000 PYR | 1.2 | 1.7 | 2 | 2 | 2 | |
HR* (95% CI) | Ref | 1.39 (1.21 to 1.60)§ | 1.58 (1.36 to 1.84)§ | 1.62 (1.38 to 1.90)§ | 1.62 (1.35 to 1.94)§ | |
P value | – | <0.001 | <0.001 | <0.001 | <0.001 |
*Adjusted for sex, age, insurance type, income, number of visits, number of providers, level of hospital and comorbidities
†p<.05
‡p<.01
§p<0.001
CAD, coronary artery disease; MPR, medication possession ratio; N, Number; PYR, person-years at risk.